glp-1 heart muscle Mechanisms of Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic Benefit GLP-1 receptor agonists improve cardiovascular

Originally for diabetes and weight loss, new studies have shown they could protect brain cells and preserve memory

Consider reducing from 12mg to 8mg for 4 weeks, then 8mg to 4mg for 4 weeks before stopping

Based on these criteria, Novo Nordisk estimates that approximately 10% of people with obesity would meet the indication

Semaglutide injections are well-tolerated after gastric sleeve because they work systemically rather than requiring large oral tablets that might irritate a small pouch or cause dumping syndrome

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Barley -glucan improves metabolic condition via short-chain fatty acids produced by gut microbial fermentation in high fat diet fed mice